Clinical Interventions and Diagnostics Branch
The Clinical Interventions and Diagnostics Branch supports research on the prevention, treatment, and management of individuals with or at-risk for cognitive decline, Alzheimer's disease, and related dementias. The branch supports all stages of clinical development for pharmacologic and nonpharmacologic interventions and combination therapies, as well as research on methods development and training for innovative trial design. The branch also supports research on diagnostics aimed at the development and evaluation of reliable and valid multidimensional diagnostic procedures and instruments, including imaging, fluid and digital biomarkers, and clinical and neuropsychological instruments for diagnosis, progression, and response to treatment. A central goal of the branch is the maintenance and development of research infrastructure for clinical trials and biomarkers development, which includes the national network of Alzheimer’s Disease Research Centers.
Alvin McKelvy, Ph.D.
Health Science Specialist
Email Alvin McKelvy
Akanni Clarke, Ph.D.
Email Akanni Clarke
Biomarkers and Diagnostics
Alzheimer’s Disease Research Centers
Training and Technology
Recruitment and Retention
Learn more about the Clinical Interventions and Diagnostics Portfolio.